4523 N logo

Eisai BMV:4523 N Stock Report

Last Price

Mex$888.98

Market Cap

Mex$218.9b

7D

0%

1Y

n/a

Updated

14 Feb, 2024

Data

Company Financials +

Eisai Co., Ltd.

BMV:4523 N Stock Report

Market Cap: Mex$218.9b

4523 N Stock Overview

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. More details

4523 N fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance4/6
Financial Health6/6
Dividends3/6

Rewards

Earnings are forecast to grow 16.51% per year

Earnings grew by 70.1% over the past year

Risk Analysis

Dividend of 2.44% is not well covered by earnings or cash flows

Shares are highly illiquid


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Eisai Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Eisai
Historical stock prices
Current Share PriceJP¥888.98
52 Week HighJP¥1,064.45
52 Week LowJP¥888.98
Beta-0.021
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-38.75%
5 Year Changen/a
Change since IPO-36.25%

Recent News & Updates

Recent updates

Shareholder Returns

4523 NMX PharmaceuticalsMX Market
7D0%5.9%1.6%
1Yn/a-6.8%-3.5%

Return vs Industry: Insufficient data to determine how 4523 N performed against the MX Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 4523 N performed against the MX Market.

Price Volatility

Is 4523 N's price volatile compared to industry and market?
4523 N volatility
4523 N Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement4.9%
10% most volatile stocks in MX Market8.8%
10% least volatile stocks in MX Market2.7%

Stable Share Price: 4523 N has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 4523 N's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
194111,076Haruo Naitowww.eisai.co.jp

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor; Aricept, for Alzheimer's disease/Dementia with Lewy bodies; and Chocola BB plus for the preparation vitamin B2.

Eisai Co., Ltd. Fundamentals Summary

How do Eisai's earnings and revenue compare to its market cap?
4523 N fundamental statistics
Market capMex$218.90b
Earnings (TTM)Mex$5.18b
Revenue (TTM)Mex$85.55b

41.4x

P/E Ratio

2.5x

P/S Ratio

Is 4523 N overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4523 N income statement (TTM)
RevenueJP¥749.46b
Cost of RevenueJP¥157.73b
Gross ProfitJP¥591.73b
Other ExpensesJP¥546.31b
EarningsJP¥45.42b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)158.37
Gross Margin78.95%
Net Profit Margin6.06%
Debt/Equity Ratio19.7%

How did 4523 N perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

101%

Payout Ratio

Does 4523 N pay a reliable dividends?

See 4523 N dividend history and benchmarks
When do you need to buy 4523 N by to receive an upcoming dividend?
Eisai dividend dates
Ex Dividend DateMar 28 2024
Dividend Pay DateJul 01 2024
Days until Ex dividend417 days
Days until Dividend pay date322 days

Does 4523 N pay a reliable dividends?

See 4523 N dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/02/14 01:18
End of Day Share Price 2023/11/17 00:00
Earnings2023/12/31
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Eisai Co., Ltd. is covered by 25 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Atsushi SekiBarclays
Koichi MameganoBofA Global Research
Aaron HoCFRA Equity Research